Inicio > Medicina > Enfermería y servicios auxiliares > Servicios de primeros auxilios y de auxiliares sanitarios > Biomarker Tests for Molecularly Targeted Therapies
Biomarker Tests for Molecularly Targeted Therapies

Biomarker Tests for Molecularly Targeted Therapies

AA.VV

56,11 €
IVA incluido
Disponible
Editorial:
National Academies Press
Año de edición:
2016
Materia
Servicios de primeros auxilios y de auxiliares sanitarios
ISBN:
9780309381345
56,11 €
IVA incluido
Disponible

Selecciona una librería:

  • Librería Samer Atenea
  • Librería Aciertas (Toledo)
  • Kálamo Books
  • Librería Perelló (Valencia)
  • Librería Elías (Asturias)
  • Donde los libros
  • Librería Kolima (Madrid)
  • Librería Proteo (Málaga)
Sobre IBD

Every patient is unique, and the evolving field of precision medicine aims to ensure the delivery of the right treatment to the right patient at the right time. In an era of rapid advances in biomedicine and enhanced understanding of the genetic basis of disease, health care providers increasingly have access to advanced technologies that may identify molecular variations specific to an individual patient, which subsequently can be targeted for treatment. Known as biomarker tests for molecularly targeted therapies, these complex tests have the potential to enable the selection of the most beneficial treatment (and also to identify treatments that may be harmful or ineffective) for the molecular underpinnings of an individual patient’s disease. Such tests are key to unlocking the promise of precision medicine.Biomarker tests for molecularly targeted therapies represent a crucial area of focus for developing methods that could later be applicable to other areas of precision medicine. The appropriate regulatory oversight of these tests is required to ensure that they are accurate, reliable, properly validated, and appropriately implemented in clinical practice. Moreover, common evidentiary standards for assessing the beneficial impact of biomarker-guided therapy selection on patient outcomes, as well as the effective collection and sharing of information related to those outcomes, are urgently needed to better inform clinical decision making.Biomarker Tests of Molecularly Targeted Therapies examines opportunities for and challenges to the use of biomarker tests to select optimal therapy and offers recommendations to accelerate progress in this field. This report explores regulatory issues, reimbursement issues, and clinical practice issues related to the clinical development and use of biomarker tests for targeting therapies to patients. Properly validated, appropriately implemented biomarker tests hold the potential to enhance patient care and improve outcomes, and therefore addressing the challenges facing such tests is critical.

Artículos relacionados

  • Primeros auxilios. MF0272.
    Olga Martín Villaoslada
    Puede solicitar gratuitamente las soluciones a todas las actividades en el email tutor@tutorformacion.esCapacidades que se adquieren con este Manual:- Identificar las características de la asistencia como primer interviniente.- Aplicar técnicas de valoración inicial según el protocolo establecido accediendo al accidentado de forma oportuna y generando un entorno seguro.- Aplica...
    Disponible

    22,83 €

  • Direct-to-Consumer Genetic Testing
    Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The proliferation of these companies and the services they offer demonstrate a public appetite for this information and where the future of genetics may be headed; they also demonstrate the need for serious discussion about the regulatory en...
    Disponible

    35,31 €

  • Incorporating Occupational Information in Electronic Health Records
    Each year in the United States, more than 4,000 occupational fatalities and more than 3 million occupational injuries occur along with more than 160,000 cases of occupational illnesses. Incorporating patients’ occupational information into electronic health records (EHRs) could lead to more informed clinical diagnosis and treatment plans as well as more effective policies, inte...
    Disponible

    31,72 €

  • Cognitive Rehabilitation Therapy for Traumatic Brain Injury
    Traumatic brain injury (TBI) may affect 10 million people worldwide. It is considered the ’signature wound’ of the conflicts in Iraq and Afghanistan. These injuries result from a bump or blow to the head, or from external forces that cause the brain to move within the head, such as whiplash or exposure to blasts. TBI can cause an array of physical and mental health concerns and...
    Disponible

    58,19 €

  • Health IT and Patient Safety
    IOM’s 1999 landmark study To Err is Human estimated that between 44,000 and 98,000 lives are lost every year due to medical errors. This call to action has led to a number of efforts to reduce errors and provide safe and effective health care. Information technology (IT) has been identified as a way to enhance the safety and effectiveness of care. In an effort to catalyze its i...
    Disponible

    43,63 €

  • A Research Strategy for Environmental, Health, and Safety Aspects of Engineered Nanomaterials
    The nanotechnology sector, which generated about $225 billion in product sales in 2009, is predicted to expand rapidly over the next decade with the development of new technologies that have new capabilities. The increasing production and use of engineered nanomaterials (ENMs) may lead to greater exposures of workers, consumers, and the environment, and the unique scale-specifi...
    Disponible

    51,48 €